He First Fully Integrated End To Personalized Genetic Testing Service The Innovative Platform Employs Latest In Ngs Sequencing Technology And Ai Driven Precision Analytics That Drive Diagnostic Services At B2c News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mumbai (Maharashtra) [India], September 6 (ANI/NewsVoir): Avesthagen Limited, India's pioneering Systems biology genomics company, has launched AVGEN Diagnostics, the first fully integrated end-to-end personalized genetic testing service. The innovative platform employs the latest in NGS sequencing technology and AI-driven precision analytics that drive diagnostic testing services at B2C, B2B levels forging partnerships with hospitals, private clinics and health insurers. The portfolio includes tests for common diseases, customized panels for different disease conditions and comprehensive disease risk panels, interpreting all genes associated with the patient's phenotype. AVGEN Diagnostics address the USD 15bn global genetic diagnostic testing market through AvestaScan, its portfolio of NGS-driven tests that cover Whole Genome Sequencing, Whole Exome Sequencing and CALiBRx (Directed Panel Sequencing) for early diagnosis and risk management of heritable conditions. The portfolio ....

South Africa , United Kingdom , Villoo Morawala Patell , Zoroastrian Parsi , Calibrx Directed Panel , Avesthagen Limited , Whole Genome Sequencing , Whole Exome Sequencing , Directed Panel Sequencing , Cardiac Care Diagnostics , Carrier Screening , Pre Natal Diagnostics , Avestagenome Project , Zoroastrian Parsi Female Reference Genome , Male Reference Genome , Ulcerative Colitis , Wipro Limited , Risk Assessed , Lung Cancer Project , Genomics Sequencing , Indian Market , South Asia , Southeast Asia , Managing Director , Mumbai Maharashtra India , Eptember 6 Ani Newsvoir Avesthagen Limited ,